162 - The Art and Science of Crystallization in Pharmaceutical Development (S11E12)

From Concept to Medicine - A Comprehensive Drug Development Journey

This episode explores the critical role of crystallization in the development of active pharmaceutical ingredients (APIs). It talks about what crystallization is, and how it works to make medicines and more. Then a discussion on Polymorphism comes about. How that shape has an impact, and the structure of these methods in their many forms is highlighted.

The discussions then hit into more important notes with Yield, the need to do it and why, all the science behind how the medicine actually comes to help. What parts are being tested, and how everything is working out. It comes into full focus as to why these processes matter so much.

2025-05-24 13 min Transcript

Available Results

Generated results are saved to the knowledge database for reuse and search.

No generated results are available for this episode yet.

Extract Knowledge

Pick what you want extracted first. Model, scope, and chapter options appear after a template is selected.

Generated results for public episodes are saved to the knowledge database so they can be reused and searched later.

Transcript

Think about that tiny pill you might take. Seems
pretty simple, right? Deceptively simple, maybe?
Yeah. But what if I told you there's this hidden
world of incredible complexity inside, like a
really carefully controlled process that's crucial
for making sure it actually works? That's spot
on, and right at the heart of creating these
life -saving medicines is, well, a key step called
crystallization. Crystallization, okay. Yeah,
the active pharmaceutical ingredients, APIs,
those are the bits that actually do the work.
in a drug, they very often rely on crystallization,
and how they crystallize their physical properties,
that's absolutely critical. Critical how? Like
for me taking the pill... Directly, we're talking
about things that impact how that medicine behaves
once it's actually inside your body. Okay, so
let's like peel back the label a bit, this deep
dive we're going behind the scenes. Way down...
to the molecular level to really unpack the science
of crystallization. Right. We want to explore
how scientists control this process to make sure
the quality is there and ultimately how well
the drugs you might depend on actually work.
So our mission today, understand why crystallization
is so vital in drug development. And the pretty
fascinating technique scientists use to basically
master this whole transformation. OK, let's get
into it then. Crystallization is not just about,
you know, making pretty sparkly crystals you
might see in a lab. Not at all. It's actually
a really sophisticated purification step, and
an engineering step for those APIs. Engineering.
How so? Think of it like refining and sculpting
the active ingredient, getting it into its most
effective possible form. OK. Sculpting the medicine.
I like that. And what's really fascinating is
that scientists control several key aspects of
this with incredible precision. Three big ones
are polymorphism. Whoa, slow down, polymorphism.
Sounds technical. It is a bit, but the concept
is key. Polymorphism is basically the ability
of one single chemical substance to exist in
multiple different crystal structures. Like different
arrangements of the same Lego bricks. That's
a pretty good analogy, actually. Think about
it like a key. If the key's got the wrong shapes,
the wrong cuts, it won't open the lock, right?
Even if it's made of the right metal. Polymorphism
is kind of like the shape, the internal structure
of the drug molecule's crystal. It needs the
right structure to work effectively in your body.
Ah, okay, I think I get it. So maybe one crystal
form dissolves better than another. or is more
stable. Exactly. Different polymorphs of the
exact same drug can have totally different properties.
Solubility, how well it dissolves. Stability,
how long it lasts without degrading. And bioavailability.
Bioavailability. That's about how much gets into
your system. Precisely. how much of the drug
actually makes it into your bloodstream where
it can do its job. And you can imagine this is
absolutely crucial for how well the medicine
gets absorbed and ultimately works. We actually
see this pop up in research. There was an instance
where they struggled because they couldn't develop
the right crystallization conditions to separate
some very similar molecules, regiosummers, that
inability to control the crystal form meant they
couldn't isolate the specific molecule they needed.
It really highlights how sensitive this process
is. process can be. Wow. So the actual microscopic
shape is a huge deal. It's not just having the
right chemical. It's having it in the right structural
arrangement. Absolutely. There was a drug candidate,
AMG 517, where during development they had to
recrystallize it multiple times. Multiple times.
Wow. To get the specific crystal form they needed,
they used first acetone and water, then toluene,
different solvents to nudge it into the right
structure. It really shows the level of control
required. Scientists are essentially selecting
the best crystal form for that specific medicine.
That's amazing. Okay, so polymorphism is the
internal structure, the shape. What about particle
size distribution? That sounds a bit more straightforward.
You'd think so, but particle size is just as
critical. The actual size of the API particles
and how uniform they are has a huge impact. Like
how? Well, for one, the dissolution rate. How
quickly the drug dissolves once you take it.
That's directly affected by particle size. Generally,
smaller, more uniform particles dissolve faster.
And that means it gets into your system and starts
working quicker, right? Exactly. But it also
affects things on the manufacturing side. How
well the API powder flows when they're making
tablets or filling capsules. Good flow means
you get a consistent dose in each one. Ah, okay.
No one wants half a dose. Definitely not. And
for some liquid medicines, like certain soft
gels, the particle size needs to be controlled
to be incredibly fine. We're talking like 180
micrometers or even smaller. Which is tiny. Very
tiny. Much smaller than a grain of sand. This
helps keep the liquid uniform, homogeneous, and
helps the drug get absorbed properly, especially
if it's a drug that doesn't dissolve easily in
water. Right. We see this with inhaled medicines,
too. Particle size is absolutely vital there
to make sure actually reaches the deep parts
of the lungs where it needs to work. So whether
it's a pill, a capsule, a liquid, an inhaler.
Yeah. The size of these tiny crystals is carefully
engineered. Engineered is the right word to make
sure you get the right amount of medicine at
the right time in the right place in your body.
OK. Structure, size. Yeah. What's the third key
aspect you mentioned? Purity and yield. Crystallization
is actually a fantastic purification technique.
How does it work? Well, As the desired API molecules
arrange themselves into that ordered crystal
lattice, they tend to exclude the unwanted stuff.
Impurities, byproducts from the synthesis, they
often get left behind in the liquid. So it's
like the good molecules find each other and build
a crystal, leaving the junk out. That's a simplified
way to put it, but yeah, essentially. And by
carefully optimizing the conditions, the temperature,
the solvent, how quickly you cool it, things
like that, scientists can dramatically improve
the purity. And yield. That's just how much you
get. Exactly. Yield is the amount of the desired
API you actually recover at the end. Optimizing
crystallization can significantly boost how much
usable drug you get from your starting materials.
There are examples in the scientific literature,
OPD papers for instance, showing really meticulous
control of solvents, temperature, purity checks,
leading to incredibly high purity, like 99 %
plus. Wow. So mastering crystallization isn't
just about making the drug work. It's also crucial
for making sure it's safe, pure, and that you
can actually produce enough of it efficiently.
That makes a lot of sense. It's clearly important.
It really is. And controlling this whole process,
it's definitely part art, part science. Scientists
have a whole toolkit of techniques. Okay, so
how do they control it? What are the tools in
that toolkit? Well, one of the main ones is solvent
selection. choosing the right liquid or mixture
of liquids to dissolve the API in. Why does the
solvent matter so much? Yeah, different solvents
dissolve substances differently, obviously, but
they also influence how the crystals form the
shape, the size, even which polymorph you get.
Finding the right solvent or solvent combination
is a really delicate balancing act. Sounds complex.
It can be. There are even sophisticated model
scientists use to try and predict solubility
in mixed solvents like, say, ethanol and two
-propanol mixtures. It shows you the level of
detail involved. And you see specific solvent
systems mentioned in synthesis procedures, like
n -butanoheptane for a particular compound, chosen
specifically to get the right crystallization.
So finding the perfect liquid environment is
key. Right. What else? Temperature control. hugely
important. Right, heating and cooling. Yeah,
but it's more than just hot and cold. Temperature
affects how much API can dissolve the solubility,
but also the kinetics, how fast the crystals
actually form and grow. So carefully controlling
the temperature profile, maybe cooling slowly
or holding at a certain temperature, gives scientists
a lot of influence over the final crystal properties.
Okay, solvents, temperature. What else? Seeding.
This is a really clever technique. Seeding. Like
planting seeds. Kind of. You add tiny preformed
crystals of the exact polymorph you want into
the solution. These are called seed crystals.
And what do they do? They act like templates
or nucleation sites. They basically give the
dissolved API molecules a blueprint to follow,
encouraging them to crystallize in that same
desired structure. It helps ensure you get the
right polymorph and can influence particle size
too. Ah, so it's like giving the molecules a
little nudge in the right direction. Exactly,
a very controlled nudge. And then there's managing
super saturation. Super saturation. That's basically
when you have more API dissolved in the solvent
than should normally be stable at that temperature.
It's like the solution is overloaded. This overload
is the driving force that makes the crystals
want to form. But you need that imbalance. You
need it, but you need to control it carefully.
Too much supersaturation too quickly might lead
to lots of tiny, poorly formed crystals or the
wrong polymorph. Too little, and crystallization
might be too slow or not happen at all. So scientists
manage how they create and maintain that supersaturation
level. It sounds like juggling a lot of factors.
It is. Even things like the physical equipment
matter, the design of the crystallization vessel,
how it's mixed, the connections in the plant,
especially in pilot plants moving towards large
scale. The whole layout for crystallization is
carefully considered. Wow. And how do they even
check if they got it right? How do they see these
tiny structures? Ah, well, that's where analytical
techniques come in. Very sophisticated ones.
We don't need to get into all the jargon, but
techniques like solid -state NMR nuclear magnetic
resonance can actually tell scientists which
polymorphs are present in a sample and even quantify
them. So they have ways to actually see and measure
these microscopic details. Absolutely. They need
that feedback to know if the control strategies
are working. Okay. Now, you mentioned gas result
earlier. Can you connect all this back to a real
-world example like that, making a specific drug?
Yeah, the scale -up synthesis of gastrozole is
a good case study. Optimizing crystallization
is absolutely crucial when you move from making,
say, a few grams in a lab flask to producing
potentially tons in a massive industrial reactor.
I can only imagine the challenges there. What
changes when you scale up? A lot can change.
Maintaining consistent quality is a big one.
The yield needs to stay high. The particle properties
you achieved in the lab. You need to reproduce
those reliably in much larger equipment. Why
is that so hard? Think about mixing. It's much
harder to ensure uniform mixing and temperature
throughout a huge tank compared to a small beaker.
Heat transfer is different. How you isolate the
crystal's filtration, drying that all needs to
be scaled up effectively too. Things that weren't
an issue before can suddenly become major problems.
So the recipe might need tweaking for the big
batch. Definitely. The crystallization protocol
often needs significant optimization during scale
-up. We mentioned AMG 517 earlier needing multiple
recrystallizations. That was partly to get the
purity and the specific crystal form needed for
large -scale delivery. It shows it can be an
iterative process, try something, analyze, adjust,
try again until you nail down the conditions
for large volumes. And you see this across the
board in pharmaceutical development literature.
Complex syntheses often rely heavily on a well
-optimized crystallization step somewhere along
the line to hit the required purity targets.
So figuring out that large scale crystallization,
it sounds like a really critical bottleneck almost,
bridging the gap between discovery and actually
getting medicine to patients. It's absolutely
a critical control point. And all this effort,
this meticulous control over tiny crystal details,
it really does have a direct and pretty significant
impact on you, the person potentially taking
that medication. OK, so connect the dots for
me one last time. Why should I, as someone just
taking a prescribed pill, really care about polymorphism
or particle size? Because it's the bedrock of
that medicine's safety, its efficacy, how well
it works, and its consistency. That careful control
of polymorphism, it ensures the drug dissolves
correctly in your body, gets absorbed properly,
does what it's supposed to do, the optimized
particle size. That helps guarantee you get the
same correct dose every single time you take
it. No guesswork. Right. Consistency is key.
And the rigorous purification that comes with
well -controlled crystallization. That means
you're getting a safe product free from potentially
harmful impurities left over from the manufacturing
process. So when I take that pill, I'm really
benefiting from all this incredibly precise science
and engineering that went into making those tiny
crystals just right. Exactly. It's a testament
to the rigor involved. This seemingly microscopic
process, crystallization, has a very real, very
macroscopic impact on your health and well -being.
It truly is one of the unsung heroes in making
sure the medicines we trust actually work. This
has been incredibly insightful. So just to sum
it up. Crystalization isn't just about appearance.
It's a vital, super complex process in making
APIs, the active part of drugs. Absolutely. And
scientists use this whole arsenal of techniques,
controlling solvents, temperature, seeding, supersaturation,
to precisely manage key properties like the crystal
structure or polymorphism. The particle size,
the purity, and the overall yield of how much
they get. And getting those crystallization conditions
nailed down is just essential for manufacturing
drugs safely and effectively, especially on a
large scale. It ensures the quality of the medicines
we all rely on. I couldn't have said it better
myself. So maybe the next time you take any medication,
just pause for a second. Think about the incredible
level of precision. the science, the care that
went into creating those tiny crystals inside,
making sure they perform exactly as intended.
Kind of makes you wonder, doesn't it? What other
simple things in our daily lives are hiding that
kind of intricate science, those unseen efforts
behind the scenes?

Chapters

No chapters available.